相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
Daniela Unterleuthner et al.
ANGIOGENESIS (2020)
STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis
Christina Heichler et al.
GUT (2020)
Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer
Tsvetelina Veselinova Velikova et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Interleukin-6 Promotes Epithelial-Mesenchymal Transition and Cell Invasion through Integrin β6 Upregulation in Colorectal Cancer
Qi Sun et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases
Maryanne Covington et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
STAT3/c-Myc Axis-Mediated Metabolism Alternations of Inflammation-Related Glycolysis Involve with Colorectal Carcinogenesis
Sha Zhang et al.
REJUVENATION RESEARCH (2019)
Therapeutic blockade of the interleukin-6 receptor (IL-6R) allows sIL-6R generation by proteolytic cleavage
Niklas Prenissl et al.
CYTOKINE (2019)
T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer
Seon Hee Chang
ARCHIVES OF PHARMACAL RESEARCH (2019)
Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies
Yunbin Zhang et al.
CANCER LETTERS (2019)
Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis
Chen Wei et al.
MOLECULAR CANCER (2019)
Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells
Qian Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop
Ke Xu et al.
MOLECULAR THERAPY (2019)
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Rui-Mei Feng et al.
CANCER COMMUNICATIONS (2019)
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
NaNa Keum et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy
Ana Montalban-Arques et al.
EBIOMEDICINE (2019)
Targeting STAT3 in Cancer with Nucleotide Therapeutics
Yue-Ting K. Lau et al.
CANCERS (2019)
Upregulation of mtSSB by interleukin-6 promotes cell growth through mitochondrial biogenesis-mediated telomerase activation in colorectal cancer
Gang Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Targeting colon cancer with the novel STAT3 inhibitor bruceantinol
Ning Wei et al.
ONCOGENE (2019)
Burden of colorectal cancer in China, 1990-2017: Findings from the Global Burden of Disease Study 2017
Jie Yin et al.
CHINESE JOURNAL OF CANCER RESEARCH (2019)
Interleukin (IL-6) Immunotherapy
Toshio Tanaka et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
The Role of Tumor-Associated Macrophages in Colorectal Carcinoma Progression
Xiaoming Zhong et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Tea Polysaccharides Inhibit Colitis-Associated Colorectal Cancer via Interleukin-6/STAT3 Pathway
Li Qiao Liu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)
The balance of interleukin (IL)-6, IL-6•soluble IL-6 receptor (sIL-6R), and IL-6•sIL-6R•sgp130 complexes allows simultaneous classic and trans-signaling
Paul Baran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer
David Fogelman et al.
CANCER MEDICINE (2018)
The role of the interleukin (IL)-6/IL-6 receptor axis in cancer
Mustafa Yassin Taher et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2018)
The Two-Faced Cytokine IL-6 in Host Defense and Diseases
Masashi Narazaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab
Masayasu Hara et al.
SURGERY TODAY (2017)
Regulation of EMT by STAT3 in gastrointestinal cancer (Review)
Bo Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Phosphorylation of STAT3 Promotes Vasculogenic Mimicry by Inducing Epithelial-to-Mesenchymal Transition in Colorectal Cancer
Cong Han et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2017)
Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer
Jun Zeng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Meprin Metalloproteases Generate Biologically Active Soluble Interleukin-6 Receptor to Induce Trans-Signaling
Philipp Arnold et al.
SCIENTIFIC REPORTS (2017)
The shedding protease ADAM17: Physiology and pathophysiology
Friederike Zunke et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Trans-signaling of interleukin-6 (IL-6) is mediated by the soluble IL-6 receptor, but not by soluble CD5
Samadhi Aparicio-Siegmund et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
CD90+ stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer
Phuong T. Huynh et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Colorectal cancer cell-derived interleukin-6 enhances the phagocytic capacity and migration of THP-1 cells
Kun-Yun Yeh et al.
CYTOKINE (2016)
Review of siltuximab in the treatment of multicentric Castleman's disease
Shayna Sarosiek et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2016)
Interleukin-6 trans-signaling increases the expression of carcinoembryonic antigen-related cell adhesion molecules 5 and 6 in colorectal cancer cells
Reinhild Holmer et al.
BMC CANCER (2015)
Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition
Hong Liu et al.
CARCINOGENESIS (2015)
HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells
Dae-Hee Lee et al.
CELLULAR SIGNALLING (2015)
Cytokines, IBD, and Colitis-associated Cancer
Ralph Francescone et al.
INFLAMMATORY BOWEL DISEASES (2015)
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis (vol 124, pg 1853, 2014)
Matjaz Rokavec et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)
Lara Brambilla et al.
MOLECULAR ONCOLOGY (2015)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
Versatile functions for IL-6 in metabolism and cancer
Jan Mauer et al.
TRENDS IN IMMUNOLOGY (2015)
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival
Sedef Iskit et al.
ONCOTARGET (2015)
Soluble IL6R represents a miR-34a target: potential implications for the recently identified IL-6R/STAT3/miR-34a feed-back loop
Huihui Li et al.
ONCOTARGET (2015)
Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
Do-Youn Oh et al.
CANCER RESEARCH AND TREATMENT (2015)
c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer
Kyu Sang Lee et al.
PLOS ONE (2015)
A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors
Eric Angevin et al.
CLINICAL CANCER RESEARCH (2014)
Interleukin-6: An angiogenic target in solid tumours
Kathryn Middleton et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo
Melanie Spitzner et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The IL-6/JAK/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer (Review)
Shu-Wei Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Transcriptional regulation of the survivin gene
Romain Boidot et al.
MOLECULAR BIOLOGY REPORTS (2014)
Prognostic Significance of Cyclin D1 Expression in Colorectal Cancer: A Meta-Analysis of Observational Studies
Yang Li et al.
PLOS ONE (2014)
Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development
Maximilian J. Waldner et al.
SEMINARS IN IMMUNOLOGY (2014)
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Axel Grothey et al.
LANCET (2013)
Prognostic and Clinicopathological Significance of Survivin in Colorectal Cancer: A Meta-Analysis
Andreas Krieg et al.
PLOS ONE (2013)
The changes of Th17 cells and the related cytokines in the progression of human colorectal cancers
Jiansheng Wang et al.
BMC CANCER (2012)
IL-6/IL-6 receptor system and its role in physiological and pathological conditions
Masahiko Mihara et al.
CLINICAL SCIENCE (2012)
Interleukin-6-A Key Regulator of Colorectal Cancer Development
Maximilian J. Waldner et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Aspirin promotes apoptosis in a murine model of colorectal cancer by mechanisms involving downregulation of IL-6-STAT3 signaling pathway
Yun Tian et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)
C-stage in Colon Cancer: Implications of Carcinoembryonic Antigen Biomarker in Staging, Prognosis, and Management
Pragatheeshwar Thirunavukarasu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Clinical Relevance of Serum Vascular Endothelial Growth Factor and Interleukin-6 in Patients with Colorectal Cancer
Ayman Eldesoky et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2011)
Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies
Sandra F. Martins et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2011)
IL-6: from its discovery to clinical applications
Tadamitsu Kishimoto
INTERNATIONAL IMMUNOLOGY (2010)
VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer
Maximilian J. Waldner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Roles for Inflammation and Regulatory T Cells in Colon Cancer
Susan E. Erdman et al.
TOXICOLOGIC PATHOLOGY (2010)
Survivin: A new target for anti-cancer therapy
Brid M. Ryan et al.
CANCER TREATMENT REVIEWS (2009)
Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells
Hua Xiong et al.
NEOPLASIA (2008)
Hypoxia upregulates carcinoembryonic antigen expression in cancer cells
Nina Kokkonen et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Interleukin-6 level in patients with colorectal cancer
Farideh Esfandi et al.
CANCER LETTERS (2006)
Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3
K Leslie et al.
CANCER RESEARCH (2006)
Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic antigen)
RD Blumenthal et al.
CANCER RESEARCH (2005)
Minireview: Cyclin D1: Normal and abnormal functions
MF Fu et al.
ENDOCRINOLOGY (2004)
Serum interleukin-6 levels reflect the disease status of colorectal cancer
YC Chung et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival
HT Liu et al.
BLOOD (2003)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation
JR Alt et al.
GENES & DEVELOPMENT (2000)
分享论文
